Trellus Health plc (TRLS.L)
GBp 0.58
(0.0%)
GBp 0.58
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -5.27 Million | -8.62 Million | -4.77 Million | -1.3 Million |
| Net Income | -6.8 Million | -8.81 Million | -5.9 Million | -1.52 Million |
| Depreciation & Amortization | 716 Thousand | 536 Thousand | 32 Thousand | 2000.00 |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 24 Thousand | 62 Thousand | 139 Thousand | - |
| Change in working capital | 84 Thousand | -531 Thousand | 961 Thousand | -22 Thousand |
| Other non-cash items | 856 Thousand | 123 Thousand | -2000.00 | 244 Thousand |
| Investing Cash Flow | -2.35 Million | -2.9 Million | -3.72 Million | -1.34 Million |
| Investments in PPE | -2.35 Million | -2.9 Million | -3.72 Million | -24 Thousand |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -2.35 Million | -2.9 Million | -3.64 Million | -1.32 Million |
| Financing Cash Flow | - | - | 38.51 Million | 10.01 Million |
| Debt repayment | - | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | - | - | 38.51 Million | - |
| Other Financing Activities | - | - | 38.51 Million | 10.01 Million |
| Accounts receivables | 120 Thousand | 168 Thousand | -440 Thousand | -22 Thousand |
| Accounts payables | - | - | - | - |
| Inventory | - | - | - | - |
| Other working capital | -36 Thousand | -699 Thousand | 1.4 Million | - |
| Cash at beginning of period | 19.08 Million | 31.98 Million | 3.68 Million | - |
| Cash at end of period | 12.16 Million | 19.08 Million | 31.98 Million | 7.36 Million |
| Capital Expenditure | -2.35 Million | -2.9 Million | -3.72 Million | -24 Thousand |
| Effect of forex changes on cash | 706 Thousand | -1.36 Million | -1.72 Million | - |
| Net cash flow / Change in cash | -6.91 Million | -12.89 Million | 28.29 Million | 7.36 Million |
| Free Cash Flow | -7.62 Million | -11.52 Million | -8.49 Million | -1.32 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.94 Million | -1.94 Million | -1.38 Million | -6.8 Million | -1.38 Million | -1.78 Million |
| Depreciation & Amortization | 214 Thousand | 214 Thousand | 191 Thousand | 716 Thousand | 16 Thousand | 16.5 Thousand |
| Deferred income taxes | - | - | - | - | - | -58.5 Thousand |
| Stock-based compensation | 3500.00 | 3500.00 | 2500.00 | 24 Thousand | 2500.00 | 9500.00 |
| Change in working capital | -18.5 Thousand | -18.5 Thousand | 11 Thousand | 84 Thousand | 11 Thousand | 49 Thousand |
| Other non-cash items | -102 Thousand | -102 Thousand | 102 Thousand | 856 Thousand | 277 Thousand | 151 Thousand |
| Investing Cash Flow | -209.5 Thousand | -209.5 Thousand | -752 Thousand | -2.35 Million | -752 Thousand | -423.5 Thousand |
| Investments in PPE | - | - | - | -2.35 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -209.5 Thousand | -209.5 Thousand | -752 Thousand | -2.35 Million | -752 Thousand | -423.5 Thousand |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -18.5 Thousand | -18.5 Thousand | 11 Thousand | 120 Thousand | 11 Thousand | 49 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | 19.08 Million | - | - |
| Cash at end of period | -2.06 Million | -2.06 Million | -1.82 Million | 12.16 Million | -1.82 Million | -1.63 Million |
| Capital Expenditure | - | - | - | -2.35 Million | - | - |
| Effect of forex changes on cash | -2500.00 | -2500.00 | 9000.00 | 706 Thousand | 9000.00 | 344 Thousand |
| Net cash flow / Change in cash | -2.06 Million | -2.06 Million | -1.82 Million | -6.91 Million | -1.82 Million | -1.63 Million |
| Free Cash Flow | -1.84 Million | -1.84 Million | -1.07 Million | -7.62 Million | -1.07 Million | -1.55 Million |
GADS
SCKT
2121
TMIS
GWSN
FKWL